News from Fermion

Successful ANVISA Inspection at Fermion's API manufacturing plant in Oulu, Finland

Fermion passed successfully ANVISA Inspection 2016 with three minor... (4 February 2016)

Thought leadership articles

Benefits of outsourcing to sponsor companies and pharmaceutical lifecycle... (17 December 2015)

Autumn news from Fermion: expansion of the bench scale unit and HPAPI production update

The past 6 months have been a busy time for Fermion. We have successfully... (1 September 2015)

Fermion opened new suite for high potency APIs

Fermion’s strategy to develop its capabilities to fulfill customers’... (4 March 2015)

Arto Toivonen has been appointed as President of Fermion Oy

Arto Toivonen has been appointed as President of Fermion Oy, effective January... (14 January 2015)

FERMION

  • Manufacturer of Active Pharmaceutical Ingredients (API) for both generic and proprietary drug products since 1970.
  • Contract manufacturing services for APIs including oncology and highly potent compounds.

Meet us at:

  • DCAT, March 14-17, 2016, New York, NY, U.S.A
  • CPhI Japan, April 20-22, 2016, Tokyo, Japan
  • HPAPI Summit, June 21-23, 2016, Boston MA, U.S.A